We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Needle Fasciotomy Recommended for Treating Viking Disease

By HospiMedica International staff writers
Posted on 26 Jun 2018
Print article
Image: An example of Dupuytren\'s contracture on the ring finger (Photo courtesy of Wikipedia).
Image: An example of Dupuytren\'s contracture on the ring finger (Photo courtesy of Wikipedia).
A new study shows that needle release is just as effective as pharmaceutical treatment for treating Dupuytren's contracture, a pathological collagen disease that causes crooked fingers.

Researchers at the Sahlgrenska Academy (SA; Göteborg, Sweden) conducted a randomized, single-blinded controlled study that enrolled 156 patients with a Dupuytren contracture of at least 20° in the metacarpophalangeal (MCP) joint in a single finger. The patients were randomized to either percutaneous needle fasciotomy (PNF), or to treatment with injectable Clostridium Histolyticum collagenase (CCH). A single surgeon administered all treatments, and all the patients were seen after one week and blinded to further follow-up.

In addition to the procedure itself, 39 of the patients were examined by ultrasound both before and after treatment in order to compare the morphological appearance of the cord rupture. The patients were assessed after six months, one year, and two years by a single physiotherapist who was blinded to the treatment each patient had received. Outcome measures included measurements (joint motion, recurrence, or prevalence of a Dupuytren cord), and patient reported outcome measures.

The results revealed that patients treated by CCH had significantly more pain and larger skin ruptures than the patients treated by PNF, but there were no other significant outcome differences between the two methods one year after treatment. After two years, 76% of patients treated by CCH and 79% of those treated by PNF still had a straight MCP joint in the treated finger; in over 50% of the patients, no cords were detectable after two years. The study was presented as a doctoral thesis on May 10, 2018.

“In my opinion, there has been excessive faith in the ability of this drug [CCH] to break down the cord better than surgery, while in many places alternative solutions have been forgotten or never even considered,” said lead author and dissertation presenter Joakim Stromberg, MD, PhD. “The needle release is not at all as troublesome for patients. This extremely simple method does not produce as much pain afterwards, nor does it require any specific rehabilitation.”

Dupuytren's contracture, often referred to as "Viking disease," is a common ailment that affects about 10% of men and two percent of women in the Nordic countries. In this condition, a cord consisting of pathological connective tissue forms on the palmar side of the finger, which over time can prevent the finger from being straightened. The pinky and ring fingers are most commonly affected, often in both hands. The disease is most common among individuals older than 60, and has also been linked to factors such as heredity and diabetes. It often recurs and needs to be treated again.

Related Links:
Sahlgrenska Academy

New
Gold Supplier
Creatinine Meter
StatSensor Xpress Creatinine Meter
New
Mechanical Ventilator
NKV-550 Series
New
Elevating X-Ray Table
PROGNOST F
New
Radiography System
Riviera SPV

Print article

Channels

AI

view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Critical Care

view channel
Image: The new biomaterial heals tissues from the inside out (Photo courtesy of UC San Diego)

Groundbreaking Biomaterial Injected Intravenously Repairs Cells and Tissue Damaged by Heart Attack and TBI

Following a heart attack, there is development of scar tissue, which affects muscle function and can result in congestive heart failure. However, there is still no established treatment available for repairing... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.